Department of Pediatrics, Division of Critical Care Medicine, Children's National Hospital and George Washington University School of Medicine and Health Sciences, Washington, DC.
Department of Pediatrics, Division of Emergency Medicine Children's National Hospital and George Washington University School of Medicine and Health Sciences, Washington, DC.
Pediatr Crit Care Med. 2021 Feb 1;22(2):147-160. doi: 10.1097/PCC.0000000000002610.
To determine the bivariable associations between abnormalities of 28 common laboratory tests and hospital mortality and determine how mortality risks changes when the ranges are evaluated in the context of commonly used laboratory test panels.
A 2009-2016 cohort from the Health Facts (Cerner Corporation, Kansas City, MO) database.
Hospitals caring for children in ICUs.
Children cared for in ICUs with laboratory data.
None.
There were 2,987,515 laboratory measurements in 71,563 children. The distribution of laboratory test values in 10 groups defined by population percentiles demonstrated the midrange of tests was within the normal range except for those measured predominantly when significant abnormalities are suspected. Logistic regression analysis at the patient level combined the population-based groups into ranges with nonoverlapping mortality odds ratios. The most deviant test ranges associated with increased mortality risk (mortality odds ratios > 5.0) included variables associated with acidosis, coagulation abnormalities and blood loss, immune function, liver function, nutritional status, and the basic metabolic profile. The test ranges most associated with survival included normal values for chloride, pH, and bicarbonate/total Co2. When the significant test ranges from bivariable analyses were combined in commonly used test panels, they generally remained significant but were reduced as risk was distributed among the tests.
The relative importance of laboratory test ranges vary widely, with some ranges strongly associated with mortality and others strongly associated with survival. When evaluated in the context of test panels rather than isolated tests, the mortality odds ratios for the test ranges decreased but generally remained significant as risk was distributed among the components of the test panels. These data are useful to develop critical values for children in ICUs, to identify risk factors previously underappreciated, for education and training, and for future risk score development.
确定 28 项常见实验室检查异常与医院死亡率的双变量关联,并确定当在常用实验室检查组合的背景下评估范围时,死亡率风险如何变化。
来自 Health Facts(Cerner Corporation,堪萨斯城,MO)数据库的 2009-2016 年队列。
照顾 ICU 中儿童的医院。
有实验室数据的 ICU 中接受治疗的儿童。
无。
在 71563 名儿童中进行了 2987515 次实验室测量。在根据人群百分比定义的 10 个组中,实验室检测值的分布表明,除了在怀疑存在显著异常时主要测量的检测值外,检测值的中位数都在正常范围内。在患者水平上进行的逻辑回归分析将基于人群的组组合成具有非重叠死亡率优势比的范围。与增加死亡率风险相关的最异常的检测范围(死亡率优势比>5.0)包括与酸中毒、凝血异常和失血、免疫功能、肝功能、营养状况和基本代谢特征相关的变量。与生存最相关的检测范围包括氯、pH 值和碳酸氢盐/总 CO2 的正常值。当将双变量分析中的显著检测范围组合到常用的检测组合中时,它们通常仍然具有显著意义,但随着风险在检测中分布,风险会降低。
实验室检测范围的相对重要性差异很大,一些范围与死亡率密切相关,而另一些范围与生存率密切相关。当在检测组合而不是单独的检测中评估时,检测范围的死亡率优势比降低,但随着风险在检测组合的组成部分中分布,它们通常仍然具有显著意义。这些数据对于为 ICU 中的儿童制定危急值、识别以前被低估的风险因素、进行教育和培训以及未来的风险评分开发非常有用。